BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26076823)

  • 1. Urine proteomic analysis in cystinuric children with renal stones.
    Kovacevic L; Lu H; Goldfarb DS; Lakshmanan Y; Caruso JA
    J Pediatr Urol; 2015 Aug; 11(4):217.e1-6. PubMed ID: 26076823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine proteomic profiling in patients with nephrolithiasis and cystinuria.
    Kovacevic L; Caruso JA; Lu H; Kovacevic N; Lakshmanan Y; Carruthers NJ; Goldfarb DS
    Int Urol Nephrol; 2019 Apr; 51(4):593-599. PubMed ID: 30519981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Tubular Dysfunction in Pediatric Urolithiasis: Proteomic Evidence.
    Kovacevic L; Lu H; Caruso JA; Lakshmanan Y
    Urology; 2016 Jun; 92():100-5. PubMed ID: 26892647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked increase in urinary excretion of apolipoproteins in children with nephrolithiasis associated with hypercalciuria.
    Kovacevic L; Lu H; Caruso JA; Govil-Dalela T; Thomas R; Lakshmanan Y
    Pediatr Nephrol; 2017 Jun; 32(6):1029-1033. PubMed ID: 28188435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary proteomics reveals association between pediatric nephrolithiasis and cardiovascular disease.
    Kovacevic L; Lu H; Caruso JA; Kovacevic N; Lakshmanan Y
    Int Urol Nephrol; 2018 Nov; 50(11):1949-1954. PubMed ID: 30209738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of inhibitory protein profiles in the urine of children with nephrolithiasis: implication for disease prevention.
    Kovacevic L; Kovacevic N; Lakshmanan Y
    Int Urol Nephrol; 2022 Nov; 54(11):2783-2788. PubMed ID: 35879498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C, Neutrophil Gelatinase-associated Lipocalin, and Lysozyme C: Urinary Biomarkers for Detection of Early Kidney Dysfunction in Children With Urolithiasis.
    Kovacevic L; Lu H; Kovacevic N; Thomas R; Lakshmanan Y
    Urology; 2020 Sep; 143():221-226. PubMed ID: 32505622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new workflow for proteomic analysis of urinary exosomes and assessment in cystinuria patients.
    Bourderioux M; Nguyen-Khoa T; Chhuon C; Jeanson L; Tondelier D; Walczak M; Ollero M; Bekri S; Knebelmann B; Escudier E; Escudier B; Edelman A; Guerrera IC
    J Proteome Res; 2015 Jan; 14(1):567-77. PubMed ID: 25365230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystinuria: definition, epidemiology and clinical aspects.
    Trinchieri A; Dormia G; Montanari E; Zanetti G
    Arch Ital Urol Androl; 2004 Sep; 76(3):129-34. PubMed ID: 15568305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 24-hour urine parameters as it relates to age of onset of cystine stone formation.
    Lambert EH; Asplin JR; Herrell SD; Miller NL
    J Endourol; 2010 Jul; 24(7):1179-82. PubMed ID: 20624086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the Presence of Crystalluria Predict Stone Formation in Patients with Cystinuria?
    Wong KA; Pardy C; Pillay S; Athanasiou T; Rottenberg G; Bultitude M; Chandra A; Thomas K
    J Endourol; 2016 May; 30(5):609-14. PubMed ID: 26781171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory and fibrotic proteins proteomically identified as key protein constituents in urine and stone matrix of patients with kidney calculi.
    Boonla C; Tosukhowong P; Spittau B; Schlosser A; Pimratana C; Krieglstein K
    Clin Chim Acta; 2014 Feb; 429():81-9. PubMed ID: 24333391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis.
    Worcester EM; Coe FL; Evan AP; Parks JH
    BJU Int; 2006 Jun; 97(6):1285-90. PubMed ID: 16686727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a 1-year-old cystinuric patient with recurrent renal stones.
    Tanzer F; Ozgur A; Bardakci F; Cankorkmaz L; Ayan S
    Int J Urol; 2006 Oct; 13(10):1347-9. PubMed ID: 17010017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of urine alkalization on urinary inflammatory markers in cystinuric patients.
    Prot-Bertoye C; Jung V; Tostivint I; Roger K; Benoist JF; Jannot AS; Van Straaten A; Knebelmann B; Guerrera IC; Courbebaisse M
    Clin Kidney J; 2024 Mar; 17(3):sfae040. PubMed ID: 38510798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystinuria: cause of recurrent renal stones in a 4-year-old girl.
    Tangnararatchakit K; Ariyaprakai W; Tapaneya-Olarn W; Shotelersuk V; Petchthong T
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1281-6. PubMed ID: 12549807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive proteomic quantification of bladder stone progression in a cystinuric mouse model using data-independent acquisitions.
    Rose J; Basisty N; Zee T; Wehrfritz C; Bose N; Desprez PY; Kapahi P; Stoller M; Schilling B
    PLoS One; 2022; 17(6):e0250137. PubMed ID: 35771811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acalculous cystinuria.
    Stoller ML; McDonald MW; Gentle DL; Bruce J; Low RK
    J Endourol; 1997 Aug; 11(4):233-8. PubMed ID: 9376839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystinuria.
    Milliner DS
    Endocrinol Metab Clin North Am; 1990 Dec; 19(4):889-907. PubMed ID: 2081517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the natural history of presymptomatic cystinuria.
    Tokhmafshan F; Goodyer PR
    Curr Opin Nephrol Hypertens; 2023 May; 32(3):297-304. PubMed ID: 37013453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.